Article content material
Nyxoah to Take part in Upcoming Investor Conferences
Mont-Saint-Guibert, Belgium – September 5, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Firm”), a medical expertise firm centered on the event and commercialization of revolutionary options to deal with Obstructive Sleep Apnea (OSA), at present introduced that the Firm will take part in three upcoming investor conferences in New York Metropolis.
Olivier Taelman, Nyxoah’s Chief Govt Officer, will ship company updates on the Baird International Healthcare Convention on Tuesday, September 10, 2024, at 12:15pm ET, the H.C. Wainwright twenty sixth Annual International Funding Convention on Wednesday, September 11, 2024, at 11:00am ET and the Cantor International Healthcare Convention on Wednesday, September 18, 2024 at 1:55pm ET. Webcasts of the displays might be obtainable on the Occasions part of Nyxoah’s Investor Relations web site. The Firm can even be obtainable for 1×1 conferences with institutional traders attending the occasions.
Article content material
Nyxoah’s Investor Presentation may be accessed on the Shareholder Info part of the Firm’s Investor Relations web page.
About Nyxoah
Nyxoah is a medical expertise firm centered on the event and commercialization of revolutionary options to deal with Obstructive Sleep Apnea (OSA). Nyxoah’s lead resolution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation remedy for OSA, the world’s commonest sleep disordered respiration situation that’s related to elevated mortality threat and cardiovascular comorbidities. Nyxoah is pushed by the imaginative and prescient that OSA sufferers ought to take pleasure in restful nights and really feel enabled to dwell their life to its fullest.
For extra info, please see the Firm’s annual report for the monetary yr 2023 and go to http://www.nyxoah.com/.
Warning – CE marked since 2019. Investigational machine in the US. Restricted by U.S. federal legislation to investigational use in the US.
Ahead-looking statements
Sure statements, beliefs and opinions on this press launch are forward-looking, which replicate the Firm’s or, as applicable, the Firm administrators’ or managements’ present expectations concerning the entry into of the mortgage facility settlement and the artificial warrant settlement with the EIB; the usage of proceeds from the mortgage facility settlement; the Genio® system and ongoing scientific research of the Genio® system; the potential benefits of the Genio® system; Nyxoah’s objectives with respect to the event, regulatory pathway and potential use of the Genio® system; the utility of scientific knowledge in doubtlessly acquiring FDA approval of the Genio® system; reporting knowledge from Nyxoah’s DREAM U.S. pivotal trial; submitting for FDA approval; and entrance to the U.S. market. By their nature, forward-looking statements contain quite a few dangers, uncertainties, assumptions and different components that might trigger precise outcomes or occasions to vary materially from these expressed or implied by the forward-looking statements. These dangers, uncertainties, assumptions and components might adversely have an effect on the end result and monetary results of the plans and occasions described herein. Moreover, these dangers and uncertainties embody, however aren’t restricted to, the dangers and uncertainties set forth within the “Threat Elements” part of the Firm’s Annual Report on Type 20-F for the yr ended December 31, 2023, filed with the Securities and Change Fee (“SEC”) on March 20, 2024, and subsequent reviews that the Firm information with the SEC. A large number of things together with, however not restricted to, adjustments in demand, competitors and expertise, could cause precise occasions, efficiency or outcomes to vary considerably from any anticipated growth. Ahead wanting statements contained on this press launch concerning previous tendencies or actions aren’t ensures of future efficiency and shouldn’t be taken as a illustration that such tendencies or actions will proceed sooner or later. As well as, even when precise outcomes or developments are per the forward-looking statements contained on this press launch, these outcomes or developments might not be indicative of outcomes or developments in future intervals. No representations and warranties are made as to the accuracy or equity of such forward-looking statements. In consequence, the Firm expressly disclaims any obligation or enterprise to launch any updates or revisions to any forward-looking statements on this press launch because of any change in expectations or any change in occasions, circumstances, assumptions or circumstances on which these forward-looking statements are primarily based, besides if particularly required to take action by legislation or regulation. Neither the Firm nor its advisers or representatives nor any of its subsidiary undertakings or any such particular person’s officers or staff ensures that the assumptions underlying such forward-looking statements are free from errors nor does both settle for any duty for the long run accuracy of the forward-looking statements contained on this press launch or the precise prevalence of the forecasted developments. You shouldn’t place undue reliance on forward-looking statements, which converse solely as of the date of this press launch.
Contacts:
Nyxoah
Loïc Moreau, Chief Monetary Officer
IR@nyxoah.com
For Media
Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be
Worldwide/Germany
MC Companies – Anne Hennecke
nyxoah@mc-services.eu
Attachment
Share this text in your social community
